Tenelin Tablet 20 mg (Teneligliptin Hydrate)

Adult dose

The recommended dosage of this medication for monotherapy or combination therapy is 20 mg once daily. It can be taken regardless of meals. When co-administered with sulfonylureas, a reduction in the dose of sulfonylureas should be considered. There is no need to adjust the dosage in patients with renal impairment or mild to moderate liver impairment.

This medication should not be used in patients with allergies to the active ingredient or any other ingredients. This medication is not suitable for patients with diabetic ketoacidosis, severe diabetic coma, or type 1 diabetes. In such cases, immediate blood glucose control with insulin or fluids is necessary. Insulin therapy is also required in patients with severe infections, during and after surgery, or those with significant trauma; therefore, the use of this medication is not recommended. Caution is advised when using this medication in some patients with severely impaired liver function or heart failure. Particularly, it is better to avoid use in cases of severe heart failure. Patients taking sulfonylureas or insulin should be cautious due to the risk of hypoglycemia. Patients with poor nutritional status, irregular meal intake, vigorous exercise, or excessive alcohol consumption may risk hypoglycemia. Patients with a history of abdominal surgery or intestinal obstruction also require caution when using this medication. Patients who may be affected by heart rhythm, such as those with arrhythmias or heart failure, or those with hypokalemia should consult a doctor before using this medication. Symptoms of acute pancreatitis may occur, so if there is persistent abdominal pain or vomiting, immediate consultation with medical staff is required. When using this medication, one must be well-versed in the symptoms of hypoglycemia, and appropriate measures such as consuming sugar-containing food are necessary if symptoms appear. Additionally, the risk of hypoglycemia may increase when this medication is used in combination with other diabetes drugs, so it is essential to carefully review the medication regimen. Pregnant or nursing women should carefully consider the use of this medication and consult a specialist if necessary. There has not been enough confirmation of safety and efficacy in children or elderly individuals, so extra care is needed when administering this medication. In case of overdose, general treatment should be administered and the patient's condition should be closely monitored. This medication should be kept out of reach of children and should not be transferred to another container. Finally, if joint pain or skin blisters occur during the use of this medication, immediate medical attention should be sought.

Serious side effects

Urticaria, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with high fever, blisters, skin peeling, pain in mucous membranes of the mouth/eyes, shortness of breath or difficulty breathing, asthma attack, respiratory distress accompanied by cough and fever, yellowing of skin or eyes (jaundice), extreme lethargy, sudden and severe headache, thunderclap headache, seizures, confusion of consciousness, visual disturbances, paralysis, urination

Mild side effects

• Hypoglycemia
• constipation
• dizziness
• headache
• weakness
• hunger
• fatigue
• facial swelling
• diarrhea
• indigestion

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture, and it is advisable to keep it at room temperature between 1°C and 30°C. Proper storage will help maintain the medication's effectiveness for an extended period.

Appearance

Pink round film-coated tablet

Package unit

30 tablets/bottle, 60 tablets/bottle